Clinical trial
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In…
NCT00452842 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00452842 |
|---|---|
| Title | Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies |
| Official title | An Observational Safety Follow Up Trial Of The Occurrence Of Major Cardiovascular Events And All Cause Mortality In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Clinical Trials. |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Cardiovascular Disease, Cerebrovascular Disorders |
| Enrollment | 26,784 |
| Start date | Oct 1, 2007 |
| First posted | Mar 28, 2007 |
| Last update posted | Feb 22, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: